Keywords: accentia, fy, loss, soars, costs, florida, usa-based
Accentia's FY 2007 loss soars 68% on R&D costs
Article | 14 January 2008
Florida, USA-based Accentia Biopharmaceuticals says that, for the fiscal year ended September 30, 2007, its net loss on a fully consolidated basis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
